National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 11/07/2008



General Information About Childhood Central Nervous System Embryonal Tumors






Staging Childhood Central Nervous System Embryonal Tumors






Recurrent Childhood Central Nervous System Embryonal Tumors






Treatment Option Overview






Treatment Options for Childhood Central Nervous System Embryonal Tumors






To Learn More About Childhood Central Nervous System Embryonal Tumors






Get More Information From NCI






Changes to This Summary (11/07/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Staging Childhood Central Nervous System Embryonal Tumors

Key Points for This Section


Treatment is based on the child’s risk group.

Staging is the process used to find out how much cancer there is and if cancer has spread. It is important to know the stage in order to plan treatment.

There is no standard staging system for childhood central nervous system (CNS) embryonal tumors. Instead, treatment depends on the child’s risk group:

Average risk

Childhood CNS embryonal tumors are called average risk when all of the following are true:

  • The child is older than 3 years of age.
  • The tumor is at the very back of the brain.
  • All of the tumor was removed by surgery or there was only a very small amount remaining.
  • The cancer has not spread to other parts of the body.

High risk

Childhood CNS embryonal tumors are called high risk if any of the following are true:

  • The child is 3 years of age or younger.
  • The tumor is not at the very back of the brain.
  • Some of the tumor was not removed by surgery.
  • The cancer has spread to other parts of the body.

In general, cancer is more likely to recur (come back) in patients in the high-risk group.

There are three ways that cancer spreads in the body.

The three ways that cancer spreads in the body are:

  • Through tissue. Cancer invades the surrounding normal tissue.
  • Through the lymph system. Cancer invades the lymph system and travels through the lymph vessels to other places in the body.
  • Through the blood. Cancer invades the veins and capillaries and travels through the blood to other places in the body.

When cancer cells break away from the primary (original) tumor and travel through the lymph or blood to other places in the body, another (secondary) tumor may form. This process is called metastasis. The secondary (metastatic) tumor is the same type of cancer as the primary tumor. For example, if breast cancer spreads to the bones, the cancer cells in the bones are actually breast cancer cells. The disease is metastatic breast cancer, not bone cancer.

The information from tests and procedures done to detect (find) childhood CNS embryonal tumors is used to plan cancer treatment.

Some of the tests used to detect childhood CNS embryonal tumors are repeated after the tumor is removed by surgery. (See the General Information section.) This is to find out how much tumor remains after surgery. Other tests and procedures may be done to find out if the cancer has spread:

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov